Glen Dalakian is an associate in Ropes & Gray’s litigation and enforcement practice, where he represents clients in government investigations, internal investigations, and regulatory enforcement matters. He advises healthcare and life sciences companies, hospital systems, academic medical centers, and other organizations responding to inquiries and investigations by the U.S. Department of Justice, the Federal Trade Commission, and state attorneys general.
Glen has extensive experience defending clients in False Claims Act and antitrust matters, conducting sensitive internal investigations involving allegations of executive and employee misconduct, and advising organizations on data privacy and cybersecurity issues. He represents clients throughout the lifecycle of government inquiries—from responding to subpoenas and civil investigative demands to developing investigative strategy, managing fact development, and negotiating resolutions with enforcement authorities. Glen also counsels healthcare organizations on antitrust risk and compliance considerations.
Glen brings a business-oriented perspective to his practice, informed by his experience managing an international venture capital fund and working as a business journalist in Beirut, where he covered entrepreneurship, innovation, and emerging markets across the Middle East. These experiences provide him with a practical understanding of the strategic, operational, and reputational challenges clients face when navigating significant legal and regulatory matters.
Glen maintains an active pro bono practice, representing individuals in federal criminal proceedings through the Southern District of New York’s Criminal Justice Act Panel and advocating for clients seeking refugee protection and resettlement. Before joining Ropes & Gray, Glen held positions with the U.S. Department of State, the Federal Reserve, The Legal Aid Society, and the U.S. House of Representatives. He graduated from Fordham University School of Law where he served as Executive Notes Editor of the Fordham Law Review.
Experience
- Advising medical schools responding to DOJ investigations into alleged civil rights violations related to admission practices.
- Representing a public university hospital facing an FCA investigation into alleged false claims submitted to government payors.
- Conducting a sensitive internal investigation to support a national healthcare company navigating alleged misconduct by a company executive.
- Representing a national home healthcare company facing an FCA investigation into reimbursement claims submitted to government payors.
- Representing a public university facing an FCA investigation into alleged false claims submitted to NIH by a faculty researcher.
- Representing a regional hospital system responding to multidistrict litigation related to national data breach incident affecting millions of patients.
- Represented an international venture capital fund responding to subpoenas by the FTC to testify in a high-profile antitrust lawsuit.
- Represented one of the largest home healthcare companies in an industrywide investigation by the DOJ Antitrust Division into price-fixing allegations related to payor rate negotiations, ultimately resulting in a declination to indict by the government.
- Represented an international pharmaceutical company responding to a Second Request by the FTC related to its proposed licensing agreement with a drug developer.
- Represented a large hospital in New Jersey responding to a Second Request by the FTC related to its proposed acquisition by another hospital system.
- Counseled an academic hospital system considering a merger with another hospital system regarding antitrust risks and potential merger review.
- Conducted client employee trainings about antitrust risks in the healthcare space.
- Represented directors of international media company facing litigation brought by former stockholders of Viacom and former stockholders of CBS challenging the multi-billion dollar merger of Viacom and CBS, resulting in settlement prior to trial.
- Conducted an internal investigation on behalf of a special committee of the board of a pharmaceutical company into potential board member and leadership misconduct.
- Conducted an internal investigation on behalf of the board of a large private equity fund into misconduct and mismanagement by portfolio company leadership.
- Represented major financial firm responding to an SEC investigation into SPAC transaction.
- Represented criminal defendant facing federal money laundering conspiracy prosecution.
- Represented refugee families seeking asylum, leading to resettlement in the United States.